Follow-up care is important for patients with non-Hodgkin lymphoma (NHL). The frequency of clinical visits, laboratory tests, and CT scans or other imaging should be discussed with the treating doctor. Periodic assessment of the patient’s state of health, blood cell counts and, if indicated, bone marrow, is important. Over time, the interval between assessments may be lengthened, but assessments should be continued indefinitely for most patients.
Click here for information about follow-up care, including what to expect, long-term and late effects of treatment, survivorship clinics, and other resources such as The National Comprehensive Cancer Network (NCCN) treatment guidelines.